NYSEHealth CareHealth Care FacilitiesS&P SmallCap 600
$208.85
+1.23 (+0.59%)
Close of Nov 06, 2026 · end-of-day data
NHC 8-K filings in 2025
Every material Form 8-K National Healthcare filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
National HealthCare appointed Dr. Lisa Piercey to its board effective November 6, 2025, and named her to the Audit Committee. The company also said President and COO R. Michael Ussery will retire December 31, 2025, after which CEO Stephen F. Flatt will also serve as president and Timothy J. Shelly will become principal operating officer.
Dr. Lisa Piercey appointed director effective November 6, 2025; independent director and Audit Committee member
Piercey is intended as a nominee for a three-year term at the 2026 Annual Meeting of Shareholders
R. Michael Ussery retires as President and COO effective December 31, 2025
Stephen F. Flatt, CEO since January 1, 2017, will also serve as president; Timothy J. Shelly becomes principal operating officer
National HealthCare Corporation reported third quarter 2025 results, with net operating revenues up 12.5% year over year to $382.7 million, driven by an 8.7% increase in same-facility revenues and the August 2024 acquisition of White Oak Management. GAAP net income attributable to NHC fell to $39.2 million from $42.8 million, while adjusted (non-GAAP) net income rose 24.3% to $24.7 million, so shareholders see higher revenue and adjusted earnings alongside lower reported GAAP profit.
Net operating revenues were $382.7 million for the quarter ended September 30, 2025, versus $340.2 million a year earlier.
GAAP diluted EPS was $2.50, down from $2.73; adjusted diluted EPS was $1.58, up from $1.27.
GAAP net income attributable to NHC was $39.2 million, versus $42.8 million; the adjusted figure excludes unrealized gains on marketable equity securities.
Dividends declared were $0.64 per common share, up from $0.61.
National HealthCare Corporation (NHC) said its President and Chief Operating Officer, R. Michael Ussery, intends to retire effective December 31, 2025, after notifying the company on September 23, 2025. The filing states that his decision did not involve any disagreement with the company, and he will continue in both roles until he retires. Shareholders will see a change in the company's senior operating leadership at year-end, though the filing does not name a successor.
Ussery has been with the company since 1980 and was appointed Chief Operating Officer on January 1, 2009, and President on January 1, 2017.
Retirement is effective December 31, 2025; the filing states it did not involve any disagreement with the company.
CEO Steve Flatt is quoted in the September 26, 2025 press release (Exhibit 99.1) thanking Ussery for his contributions.
National HealthCare reported net operating revenues of $374.9 million for the quarter ended June 30, 2025, up 24.7% from $300.7 million a year earlier, driven by a 9.6% rise in same-facility revenues and the August 1, 2024 acquisition of White Oak Management. GAAP net income attributable to NHC fell to $23.7 million from $26.8 million, while adjusted net income rose 64.7% to $25.7 million, so shareholders see higher revenue and adjusted earnings alongside lower GAAP earnings.
Net operating revenues $374.9 million vs $300.7 million, up 24.7%; same-facility net operating revenues up 9.6%
GAAP net income attributable to NHC $23.7 million vs $26.8 million; GAAP diluted EPS $1.52 vs $1.73
Adjusted net income $25.7 million vs $15.6 million, up 64.7%; adjusted diluted EPS $1.65 vs $1.00
Dividends declared of $0.64 per common share for the quarter vs $0.61 a year earlier
NHC reported first-quarter 2025 results for the quarter ended March 31, 2025. Net operating revenues rose 25.7% year over year to $373.7 million, driven by an 8.5% increase in same-facility revenue and the August 1, 2024 acquisition of White Oak Management, Inc. GAAP net income attributable to NHC increased to $32.2 million, or $2.07 per diluted share, from $26.2 million, or $1.69 per diluted share, a year earlier.
Net operating revenues were $373.7 million versus $297.2 million in the first quarter of 2024, an increase of 25.7%.
GAAP net income attributable to NHC was $32.2 million, compared with $26.2 million a year earlier.
Adjusted diluted EPS was $1.59 versus $0.99 a year earlier; adjusted net income was $24.8 million versus $15.4 million.
Same-facility net operating revenues rose 8.5%; the White Oak acquisition closed August 1, 2024.
National HealthCare reported full-year 2024 net operating revenues and grant income of $1,307,382,000, up 14.5% from 2023, and GAAP net income attributable to NHC of $101,927,000, up from $66,798,000. Fourth-quarter GAAP net income fell to $6,081,000 from $28,406,000, mainly due to an unrealized loss of $25,332,000 on marketable equity securities, while adjusted net income rose 62.7% to $25,954,000.
Full-year 2024 GAAP diluted EPS was $6.53, compared with $4.34 in 2023; adjusted diluted EPS was $4.93, compared with $3.55.
Fourth-quarter 2024 GAAP diluted EPS was $0.39, compared with $1.83 in the fourth quarter of 2023; adjusted diluted EPS was $1.66, compared with $1.03.
Full-year revenue growth reflected a 9.4% increase in same-facility net operating revenues and the August 1, 2024 acquisition of White Oak Manor.
The filing does not include forward-looking guidance for 2025; the full press release is attached as Exhibit 99.1.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every National Healthcare filing is on SEC EDGAR ↗. 8-K briefs of other companies →